Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Immuron Ltd Report Publication Announcement 2011

Sep 5, 2011

35121_rns_2011-09-05_e4e40fc7-ed8d-4bca-98c5-ee53ef5dd316.pdf

Report Publication Announcement

Open in viewer

Opens in your device viewer

==> picture [188 x 41] intentionally omitted <==

ABN: 80 063 114 045 Level 1, 39 Leveson Street North Melbourne, Vic 3051 Tel: +61 3 8637 1107 Fax: +61 3 9328 1675 www.immuron.com

6 September 2011

ASX Announcement

Immuron Limited Research Report

Immuron Limited is pleased to announce that it has commissioned Alpha Securities to prepare a research report on the Company’s Progressing Development of NASH and Influenza Drug Candidates.

This research report is available for viewing or downloaded from the Company’s website under the Investor Relations and News section, shareholder information tab; www.immuron.com

==> picture [210 x 96] intentionally omitted <==

Graeme Stevens Company Secretary

1